Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10858410
Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier
granted -
US 10858399
Peptide compositions
granted -
US 10858335
2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use
granted -
US 10857148
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10858396
HER2 peptide regents and methods
granted -
US 10857382
Compositions and methods for treating and preventing chronic pain
granted -
US 10858363
SGC stimulators
granted -
US 10857265
Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use
granted -
US 10857196
Bicyclic peptide ligands and uses thereof
granted -
US 10858347
Multicyclic compounds and uses thereof
granted -
US 10858338
Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH)
granted -
US 10857203
Methods and compositions for treating Huntington's disease
granted -
US 10857219
Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
granted -
US 10857205
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 10857185
Compositions and methods for reprogramming non-neuronal cells into neuron-like cells
granted -
US 10857174
Morpholino oligonucleotides useful in cancer treatment
granted -
US 10857165
Skeletal removal of bisphosphonates
granted -
US 10857162
Compositions for improving cell viability and methods of use thereof
granted -
US 10857126
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 10857140
K-Ras modulators
granted -
US 10857114
Compositions and methods for treating severe pain
granted -
US 2020376145
GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS
granted -
US 10849960
Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer
granted -
US 10849869
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.